Stock Events

Stock Events

IO Biotech 

$0.05
0
-$0.15-75.1% Today

Statistics

Day High
0.06
Day Low
0.04
52W High
-
52W Low
-
Volume
183,392,452
Avg. Volume
-
Mkt Cap
3.63M
P/E Ratio
-
Dividend Yield
-
Dividend
-

Upcoming

Earnings

19MayExpected
Q3 2025
Q4 2025
Next
-0.32
-0.25
-0.17
-0.1
Expected EPS
-0.1
Actual EPS
N/A

Financials

-Profit Margin
Unprofitable
2021
2022
2023
2024
0Revenue
-190.98MNet Income

Analyst Ratings

$0.50Average Price Target
The highest estimate is 0.50.
From 1 ratings within the last 6 months. This is not an investment recommendation.
Buy
0%
Hold
100%
Sell
0%

People Also Follow

This list is based on the watchlists of people on Stock Events who follow IOBT.BOATS. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
BioNTech
BNTX
Mkt Cap24.99B
BioNTech SE is a competitor because it also focuses on developing immunotherapies for cancer and other serious diseases, similar to IO Biotech's focus on novel immune-modulating cancer therapies.
Moderna
MRNA
Mkt Cap10.61B
Moderna, Inc. is involved in creating mRNA-based therapies, including cancer vaccines, which puts it in direct competition with IO Biotech's immunotherapy research.
Novavax
NVAX
Mkt Cap1.36B
Novavax, Inc. competes in the development of vaccines for serious infectious diseases but its technology and approach to stimulating immune responses can be seen as competitive to IO Biotech's work in cancer immunotherapy.
Gilead Sciences
GILD
Mkt Cap148.78B
Gilead Sciences, Inc. has a broad portfolio including oncology, making it a competitor due to its involvement in developing treatments for cancer, similar to IO Biotech's focus.
AMGEN
AMGN
Mkt Cap160.66B
Amgen Inc. is a biotechnology company with efforts in oncology and therapeutics that could compete with IO Biotech's cancer immunotherapy products.
Pfizer
PFE
Mkt Cap140.15B
Pfizer Inc. has a diverse range of biopharmaceutical products, including cancer treatments, making it a competitor in the oncology space alongside IO Biotech.
Bristol-Myers Squibb
BMY
Mkt Cap93.79B
Bristol-Myers Squibb Company is heavily involved in cancer research and drug development, positioning it as a competitor to IO Biotech in the oncology market.
Merck
MRK
Mkt Cap214.76B
Merck & Co., Inc. is a leading pharmaceutical company with a strong emphasis on cancer treatments, including immunotherapy, making it a direct competitor to IO Biotech.
Roche
RHHBY
Mkt Cap258.9B
Roche Holding AG engages in the research and development of medical drugs, including cancer immunotherapies, which competes with IO Biotech's focus area.
Astrazeneca
AZN
Mkt Cap256.58B
AstraZeneca PLC is involved in the discovery and development of new cancer treatments, including immunotherapies, making it a competitor in the same field as IO Biotech.

About

IO Biotech, Inc., a clinical-stage biopharmaceutical company, develops immune-modulating cancer therapies based on the T-win technology platform. The company's lead product candidate, IO102-IO103, which is designed to target immunosuppressive proteins, such as Indoleamine 2,3-dehydrogenase (IDO), and programmed death-ligand (PD-L1) that is in phase 2 clinical trial to treat melanoma, as well as in phase 1 clinical trial to treat lung, head and neck, bladder, and melanoma cancer. It also develops IO112, a product candidate that contains a single Arginase 1-derived peptide designed to target T cells that recognize epitopes derived from Arginase 1 for the treatment of cancers. The company was incorporated in 2014 and is based in Copenhagen, Denmark.
Show more...
CEO
ISIN
US4497781090

Listings

XNAS
US
IOBT
BOATS
BOATS
IOBT.BOATS

0 Comments

Share your thoughts

FAQ

What is IO Biotech stock price today?▼
The current price of IOBT.BOATS is $0.05 USD — it has decreased by -75.1% in the past 24 hours. Watch IO Biotech stock price performance more closely on the chart.
What is IO Biotech stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange IO Biotech stocks are traded under the ticker IOBT.BOATS.
What is IO Biotech market cap?▼
Today IO Biotech has the market capitalization of 3.63M
When is the next IO Biotech earnings date?▼
IO Biotech is going to release the next earnings report on May 19, 2026.
What were IO Biotech earnings last quarter?▼
IOBT.BOATS earnings for the last quarter are -0.17 USD per share, whereas the estimation was -0.21 USD resulting in a +20.31% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is IO Biotech revenue for the last year?▼
IO Biotech revenue for the last year amounts to 0 USD.
What is IO Biotech net income for the last year?▼
IOBT.BOATS net income for the last year is -190.98M USD.
When did IO Biotech complete a stock split?▼
IO Biotech has not had any recent stock splits.